EGM
MIRM icon

Engineers Gate Manager’s Mirum Pharmaceuticals MIRM Stock Holding History

Engineers Gate Manager’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$953K Buy
8,143
+5,584
+218% +$561K 0.01% 1115
2026
Q1 		$236K Sell
2,559
-8,139
-76% -$766K ﹤0.01% 1833
2025
Q4 		$845K Sell
10,698
-6,320
-37% -$454K 0.01% 1118
2025
Q3 		$1.25M Buy
17,018
+12,368
+266% +$786K 0.01% 1038
2025
Q2 		$237K Sell
4,650
-18,470
-80% -$822K ﹤0.01% 1837
2025
Q1 		$1.04M Buy
23,120
+5,906
+34% +$278K 0.02% 1036
2024
Q4 		$712K Buy
17,214
+7,634
+80% +$318K 0.01% 1214
2024
Q3 		$374K Buy
+9,580
New +$382K 0.01% 1523
2024
Q2 		– Sell
-17,122
Closed -$430K – 2129
2024
Q1 		$430K Buy
17,122
+1,077
+7% +$29.6K 0.01% 1275
2023
Q4 		$474K Buy
+16,045
New +$486K 0.01% 1205

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Engineers Gate Manager's MIRM Position: Q2 2026 in Review

Engineers Gate Manager increased its Mirum Pharmaceuticals (MIRM) stake by 218% in Q2 2026, buying an estimated $561K and bringing the position to 8,143 shares worth $953K. The position accounts for 0.01% of the portfolio, ranked #1115.

Engineers Gate Manager first reported a position in MIRM in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.25M in Q3 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Engineers Gate Manager held 8,143 shares of Mirum Pharmaceuticals worth $953K as of Q2 2026.
  • Engineers Gate Manager bought 5,584 Mirum Pharmaceuticals shares in Q2 2026, an estimated $561K.
  • Mirum Pharmaceuticals made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1115 holding.
  • Engineers Gate Manager first reported a position in Mirum Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • Engineers Gate Manager's Mirum Pharmaceuticals position peaked at $1.25M in Q3 2025.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.